Tenof 300mg tablet

• Hepatitis B virus (HBV) infection
• Treatment of HIV infection

Tenof 300mg tablet   may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.

Common side effects include:

• Diarrhea
• Nausea
• Rash
• Weakness
• Vomiting
• Fatigue
• Abdominal pain
• Increased transaminase level in blood
• Decreased phosphate level in blood
• Pain
• Dizziness
• Depression
• Insomnia (difficulty in sleeping)
• Fever
• Itching

• The dosage and treatment duration of the Tenof 300mg tablet are decided by the doctor according overall patient's health.
• This tablet should be taken with or without food, but at the fix time every day to get effective results. Don't miss a dose or overdose on the medicine.
  
  

• Tenof 300mg tablet is an antiviral medicine with Tenofovir disoproxil fumarate as an active ingredient.
• It works by preventing the multiplication of viruses in human cells to stop the production of new viruses and clears up the infection from the body.​​
  

• Chan, H. L., Fung, S., Seto, W. K., Chuang, W. L., Chen, C. Y., Kim, H. J., ... & Agarwal, K. (2016). Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. The lancet Gastroenterology & hepatology, 1(3), 185-195. https://pubmed.ncbi.nlm.nih.gov/28404091/
• Benhamou, Y., Fleury, H., Trimoulet, P., Pellegrin, I., Urbinelli, R., Katlama, C., ... & Piketty, C. (2006). Anti‐hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV‐infected patients. Hepatology, 43(3), 548-555. https://pubmed.ncbi.nlm.nih.gov/16496322/
• Agarwal, K., Brunetto, M., Seto, W. K., Lim, Y. S., Fung, S., Marcellin, P., ... & GS-US-320-0108 Investigators. (2018). 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. Journal of hepatology, 68(4), 672-681. https://pubmed.ncbi.nlm.nih.gov/29756595/
• Wassner, C., Bradley, N., & Lee, Y. (2020). A review and clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide. Journal of the International Association of Providers of AIDS Care (JIAPAC), 19, 2325958220919231. https://pubmed.ncbi.nlm.nih.gov/32295453/
• Gallant, J. E., & Deresinski, S. (2003). Tenofovir disoproxil fumarate. Clinical Infectious Diseases, 37(7), 944-950. https://pubmed.ncbi.nlm.nih.gov/13130407/